Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
ETON

Market Cap: $1.56B

EI

Eton Pharmaceuticals, Inc.

ETON

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin57.87%

EBITDA Margin17.58%

EBIT Margin14.59%

Pre-tax Margin12.08%

Net Profit Margin12.02%

Earnings Yield0.80%

Valuation Multiples

Price / Book33.87

Price / Sales14.81

Price / Earnings122.75

PEG0.17

Forward PEG1.29

EV / Sales14.83

EV / EBITDA84.34

EV / Operating Cash Flow103.45

EV / Free Cash Flow106.28

Price / Free Cash Flow106.13

Price / Operating Cash Flow104.25

Cash Flow & Capital

Free Cash Flow / Share$0.53

Operating Cash Flow / Share$0.55

Free Cash Flow Yield0.94%

Capex / Revenue0.38%

Capex / Operating Cash Flow2.66%

Capex / Depreciation0.09

Stock Compensation / Revenue4.93%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio1.52

Quick Ratio1.30

Cash Ratio0.59

Debt / Assets0.25

Debt / Capital0.38

Debt / Equity0.62

Long-Term Debt / Capital0.29

Debt / Market Cap1.78%

Net Debt / EBITDA0.12

Solvency Ratio0.23

Financial Leverage2.49

Efficiency & Working Capital

Asset Turnover0.91

Fixed Asset Turnover72.03

Inventory Turnover4.39

Receivables Turnover4.24

Payables Turnover3.09

Days Sales Outstanding86.02

Days Inventory Outstanding83.21

Days Payables Outstanding118.17

Operating Cycle169.23

Cash Conversion Cycle51.06

Working Capital Turnover6.49

Returns & Quality

Return on Equity40.13%

Return on Assets10.96%

Return on Invested Capital20.41%

ROCE23.07%

Return on Tangible Assets18.09%

Operating Return on Assets15.28%

Income Quality1.19

Tax Burden1.00

Interest Burden0.83

Balance Sheet & Intrinsic Metrics

Enterprise Value$1.57B

Invested Capital$70.62M

Working Capital$23.48M

Tangible Asset Value$907K

Net Current Asset Value$-623K

Graham Number$4.17

Graham Net-Net-$0.67

Book Value / Share$1.69

Tangible Book Value / Share$0.03

Cash / Share$0.97

Financial Health Scores

Piotroski Score7

Altman Z-Score14.11

Revenue$105.6M

EBIT$15.41M

Market Cap$1.58B

Working Capital$23.48M

Retained Earnings$-99.36M

Total Assets$115.81M

Total Liabilities$69.22M